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Variation in gene content among strains of a bacterial species contributes to biomedically relevant differences in phenotypes
such as virulence and antimicrobial resistance. Group A Streptococcus (GAS) causes a diverse array of human infections and
sequelae, and exhibits a complex pathogenic behavior. To enhance our understanding of genotype-phenotype relationships in
this important pathogen, we determined the complete genome sequences of four GAS strains expressing M protein serotypes
(M2, M4, and 2 M12) that commonly cause noninvasive and invasive infections. These sequences were compared with eight
previously determined GAS genomes and regions of variably present gene content were assessed. Consistent with the
previously determined genomes, each of the new genomes is ,1.9 Mb in size, with ,10% of the gene content of each
encoded on variably present exogenous genetic elements. Like the other GAS genomes, these four genomes are polylysogenic
and prophage encode the majority of the variably present gene content of each. In contrast to most of the previously
determined genomes, multiple exogenous integrated conjugative elements (ICEs) with characteristics of conjugative
transposons and plasmids are present in these new genomes. Cumulatively, 242 new GAS metagenome genes were identified
that were not present in the previously sequenced genomes. Importantly, ICEs accounted for 41% of the new GAS
metagenome gene content identified in these four genomes. Two large ICEs, designated 2096-RD.2 (63 kb) and 10750-RD.2
(49 kb), have multiple genes encoding resistance to antimicrobial agents, including tetracycline and erythromycin,
respectively. Also resident on these ICEs are three genes encoding inferred extracellular proteins of unknown function,
including a predicted cell surface protein that is only present in the genome of the serotype M12 strain cultured from a patient
with acute poststreptococcal glomerulonephritis. The data provide new information about the GAS metagenome and will
assist studies of pathogenesis, antimicrobial resistance, and population genomics.
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INTRODUCTION
Study of intraspecies variation in chromosomal gene content and
sequence diversity has become an area of considerable interest in
recent years [1–9]. Several factors have prompted research on this
topic. First, the genome sequences that are now available for at
least one member of many eukaryotic and prokaryotic species
provide reference templates for indexing intraspecies diversity
(cmr.tigr.org and www.genomesonline.org). Second, analysis of
intraspecies genetic diversity is a crucial component of studies
designed to understand the molecular basis of phenotypic variation
in traits such as organism behavior, disease susceptibility, and
response to pharmacologic agents. Third, sequences that are
polymorphic within members of the same species are used in
molecular epidemiology studies to distinguish among closely
related organisms for public health and forensic purposes. Fourth,
given that mutation, selection, and inheritance are the basis of
evolution, comparison of intraspecies genetic variation provides
insights into the molecular processes underlying evolution. A
major factor that has contributed to increased interest in species-
level genetic diversity among pathogenic microbes is the need to
understand the molecular basis of biomedically relevant topics
such as strain emergence, virulence differences, disease manifes-
tation, and evolution of pathogenic traits.
The human bacterial pathogen group A Streptococcus (GAS) is an
ideal model organism for studying molecular processes generating
intraspecies genomic diversity and the contribution of specific
genetic differences to host-pathogen interactions. GAS causes
a wide range of infections, including pharyngitis, cellulitis, sepsis,
necrotizing fasciitis, and post-infection sequelae including acute
rheumatic fever (ARF) and acute poststreptococcal glomerulone-
phritis (APSGN) [10–13]. For many decades, GAS strains have
been classified based on serologic differences in M protein, a highly
polymorphic cell-surface virulence factor [14,15]. More than
125 M protein types and emm gene types have been identified (for
convenience we will use the terms M protein serotype and emm
type interchangeably), and the number of subtypes is far higher
([16]; www.cdc.gov/ncidod/biotech/strep/emmtypes.htm). Im-
portantly, epidemiologic studies conducted over many decades
have repeatedly found that certain M protein types are non-
randomly associated with particular human infections [10,17–22].
For example, serotype M1 and M3 GAS strains commonly cause
pharyngitis and invasive infections, and M28 GAS strains are
significantly overrepresented among puerperal sepsis and neonatal
GAS infections [17,18,21–25]. Thus, there is a rich phenotypic
and clinical framework available for interpreting genome sequence
information. Moreover the relatively modest size, low G+C
Academic Editor: Niyaz Ahmed, Centre for DNA Fingerprinting and Diagnostics,
India
Received July 18, 2007; Accepted July 31, 2007; Published August 29, 2007
Copyright:  2007 Beres, Musser. This is an open-access article distributed
under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the
original author and source are credited.
Funding: This study was supported in part by grant UO1-60595 from the National
Institute of Allergy and Infectious Diseases (to JMM).
Competing Interests: The authors have declared that no competing interests
exist.
* To whom correspondence should be addressed. E-mail: jmmusser@tmh.tmc.
edu
PLoS ONE | www.plosone.org 1 August 2007 | Issue 8 | e800content, single chromosome, rare occurrence of extra-chromo-
somal elements, and lack of extensive repetitive sequences permits
complete GAS genome sequences to be determined at reduced
cost, time, and effort relative to many other microbial pathogens
[26–31]. In addition, the increasing number of reports from many
countries describing the emergence of GAS strains resistant to
antimicrobial agents such as erythromycin and tetracycline [32–
44] provides a public health impetus for sequencing the genome of
additional strains. In this manuscript we describe new findings
based on the genome sequence of serotype M2, M4, and two M12
strains, with a focus on unique gene content encoded by integrated
conjugative elements (ICEs).
RESULTS
Strain selection
The strains selected for sequencing were chosen on the basis of
a variety of characteristics. The primary criterion was that the
strains were of an unsequenced M protein serotype that
abundantly cause noninvasive and invasive infections. Consistent
with this serotype M2, M4 and M12 strains are all common
isolates of noninvasive and invasive infections in the United States
and other developed countries (see www.cdc.gov/ncidod/dbmd/
abcs/survreports.htm). Strains representing these serotypes have
not been previously sequenced.
An additional criterion was an epidemiologic association with
a distinct pathogenic character in order to facilitate assessment of
gene content influencing strain genotype-patient disease pheno-
type relationships or epidemic behavior. Serotype M2 strain
MGAS10270 was obtained from a patient in Texas with
pharyngitis in the late 1990s. Serotype M2 strains are associated
with female uritogenital tract infections [18,45,46]. Serotype M4
strain MGAS10750 was cultured from a patient with pharyngitis
in Florida in 2001. This strain is resistant to erythromycin (MIC
1 mg/ml) and is PCR positive for the erm(A) gene. Erythromycin
resistant serotype M4 strains have caused epidemic outbreaks of
infection [18,47,48]. Serotype M12 strain MGAS2096 was
isolated from a patient with poststreptococcal glomerulonephritis
in Trinidad in 1960. The isolation of GAS from patients with
APSGN is rare as in most cases the infection has cleared prior to
glomerulonephritis manifestation. This organism, also known as
strain A374, has been studied previously [49–51]. Given that
serotype M12 strain MGAS2096 was isolated over 45 years ago,
and changes in prophage content have been associated with rapid
shifts in GAS pathogenesis, we also elected to sequence
a contemporary M12 strain for comparison. Serotype M12 strain
MGAS9429 was cultured from a pediatric patient with pharyngitis
in the Texas in 2001. Strain MGAS9429 has the most common
prophage virulence gene profile detected from among 33 contem-
porary serotype M12 strains studied (J.M.M., unpublished data).
A repeated epidemiological finding dating back to the 1930s is
that strains of certain M protein serotypes are nonrandomly
associated with the poststreptococcal infection sequela, ARF and
APSGN [11,12,52,53]. Observations of distinct differences in
disease manifestation from these studies lead to the supposition
that rheumatogenicity and nephritogenicity may be independent
properties of two separate GAS genetic lineages that broadly
correspond with strains most commonly causing throat and skin
infections, respectively. The presence or absence of the serum
opacity factor (sof) gene encoding for a lipoproteinase that confers
the ability to opacify human serum is considered a marker of the
two lineages [54,55]. Excepting serotype M28 strain MGAS6180,
all of the previously sequenced GAS strains are sof negative and
represent serotypes considered rheumatogenic (2 each of M1 and
M3, and one each of M5, M6, and M18) (Table 1). The four
strains selected for sequencing and described here are all sof
positive representing serotypes considered nephritogenic. Thus in
addition to their other disease associations, these four genomes
also provide data for assessing genetic differences between the
posited GAS skin/nephritogenic and throat/rheumatogenic
lineages.
Overview of general genome features
Consistent with the genomes of eight previously sequenced GAS
strains [26–31,56], the serotype M2, M4 and both M12 genomes
each is a single circular chromosome of ,1.9 Mb (Table 1, Fig. 1).
The percent G+C content of these genomes is approximately
38.5%, essentially identical to the other eight sequenced GAS
genomes (range, 38.31%–38.73%). Each of these genomes has six
operons encoding adjacent 5S, 16S, and 23S ribosomal RNAs.
Each has the multi-locus sequence type (MLST) that is most
common for their M type [57]. Predicted coding sequence
composes a similar portion of each of the genomes. Among the
12sequencedGASgenomes,onaveragecodingsequenceconstitutes
86.4% of each genome, with a mean gene size of 870 nt.
The majority of each genome (.85%) is conserved in gene
content and context relative to the others (Fig. 1). This core
sequence is conserved at greater than 98% nucleotide identity and
comprises the endogenous ‘‘core’’ of the GAS metagenome (i.e.,
the common part of the chromosome that does not include
obvious exogenous genetic elements such as prophages and ICEs).
The endogenous core encodes many proven or putative secreted
virulence factors, including M protein, streptolysin O, streptolysin
S, streptokinase, pyrogenic toxin superantigens (SmeZ), collagen-
like proteins (SclA and SclB), and proteases (SpeB, Mac, and
ScpA) [11,12] to name a few. The average size of the 12
sequenced genomes is 1,882 kb, and the difference between the
smallest and largest genome is 100.6 kb or 5.3% of the average
size. The extent of size variation in the GAS genomes is similar to
that reported for Staphylococcus aureus genomes, greater than found
in Chlamydia trachomatis and Mycobacterium tuberculosis, and consid-
erably less than for certain Escherichia coli strains [1,2,4–7,9,58].
Overview of exogenous genetic elements,
prophages, and ICEs
To identify regions of difference among the sequenced GAS
genomes they were aligned pair-wise. This revealed regions (5 kb–
63 kb) differing in gene content and/or context that disrupted the
continuity of the aligned sequences (this is illustrated for the four
newly sequenced genomes in Fig. 2). Bioinformatic analysis found
that these regions of difference contain gene content similar to
prophages and ICEs. Twenty-one exogenous genetic elements (14
prophage-like and 7 ICE-like) ranging from 12 kb to 63 kb in size
were identified in the serotype M2 (5 W, 2 ICE), M4 (4 W, 2 ICE),
and M12 strains MGAS2096 (2 W, 2 ICE) and MGAS9429 (3 W,1
ICE) genomes (Fig. 1, Table 2). In total, we identified 67 obvious
exogenous genetic elements (55 prophages and 12 ICEs) integrated
at 21 distinct loci of the core chromosome in the 12 GAS genomes
(Fig. 3, Table 2). Based on gene content, some of the smaller
elements likely are remnants of ancestral genetic elements that
have undergone reductive evolution. However, we cannot exclude
the possibility that these elements are mobile and were acquired by
lateral gene transfer. As most of these exogenous genetic elements
have not been shown experimentally to be transferable we refer to
them as putatively-mobile.
All of the sequenced GAS strains have multiple prophages, most
of which encode one or two proven or putative secreted virulence
GAS Metagenome Diversity & ICE
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the major contributor to variation in gene content among the
sequenced GAS genomes [59]. As such phage have been a major
source of virulence factors uniquely present in each of the
genomes. In opposition to this prior trend, no new putative
secreted virulence factors were encoded by the 14 prophages
present in the serotype M2, M4, and M12 genomes sequenced.
Importantly however, this does not mean that the prophages in
these genomes are identical to those in the other sequenced GAS
genomes, or that no new secreted putative virulence genes were
identified in these strains. To the contrary, the apparent mobility
and highly recombinogenic mosaic structures of the prophages
and ICEs in the GAS genomes results in each sequenced GAS
genome having a unique complement of exogenous elements and
secreted virulence determinants.
In addition to multiple prophages, seven of the sequenced
strains also contain large (5 kb–63 kb) regions that have features of
ICEs [60,61]. The presence of ICEs in the newly sequenced strains
means that conjugative lateral gene transfer is a second important
contributor to GAS metagenome diversification. For example,
ICEs, 2096-RD.1 and 2096-RD.2, present in the genome of
serotype M12 strain MGAS2096 account for half (49.5%) of the
total of 162.6 kb of foreign sequence identified in this strain.
Notably, ICEs are more prevalent among the sof positive strains
(averaging 2.0 per genome) than the sof negative strains (averaging
0.3 per genome) (Table 1). Each of the five sof positive genomes
(M2, M4, 2 M12 and M28) contain one or more ICEs, accounting
for 10 of the 12 ICEs among the sequenced strains. In contrast
among the 7 sof negative genomes (2 M1, 2 M3, M5, M6, and
M18) only the two serotype M1 strains have an ICE. Furthermore,
unlike the prophage which on average differ only 0.5 percent in
G+C content (ave.=38.05) from the GAS endogenous core
genome (ave.=38.61), the ICEs differ by an average of 5 percent
(ave.=33.62) (Table 2).
To identify new GAS metagenome gene content, the predicted
CDSs of each newly sequenced strain was compared to the
genomes of the eight previously sequenced GAS strains using
BLASTN. In total 242 genes were identified that shared less than
50% overall nucleotide identity with sequence of any of the
previously determined genomes (supplementary Table S1). ICE-
like regions accounted for 41% (98/242), the fibronectin-collagen-
T antigen encoding (FCT) region 9% (22/242), and prophages
14% (33/242) of this new gene content (supplementary Table S1).
Given that ICE-like elements and the FCT region encode half of
this newly identified GAS metagenome gene content, the
description of the M2, M4, and M12 genome sequences that
follows will focus on these components. The ICEs will be
presented in order as they occur integrated clockwise around the
GAS metagenome (Fig. 3). Specific prophages in these genomes
will not be described as no new prophage associated putative
virulence genes were found in these genomes, and the contribution
of phage to GAS pathogenesis and genome diversification has
been the subject of recent reviews [59,62–64].
Streptin production ICE-like region
The genome of the serotype M2, M4, and M12 strains each has an
,15 kb ICE-like region of difference (designated 10270-RD.1,
10750-RD.1, 2096-RD.1, and 9429-RD.1) composed of 9 or 10
genes (srt genes) encoding proteins mediating production of
streptin, a lantibiotic bacteriocin (for a diagram of the srt gene
locus see [65]) (Fig. 3 site G). These genes are flanked on the 59
and 39 sides by multiple CDSs with similarity to ICE relaxases and
site-specific recombinases, respectively. This element is integrated
between rpiL and dacA1 (SF370: Spy1073&Spy1093), genes
encoding a ribosomal large subunit protein and peptidoglycan
synthesis transpeptidase, respectively. The integration of this
element appears to result in deletion of a ,200 nt region located
between these two genes. Genes encoding for streptin production
are also present at this loci in the two serotype M1 and the M28
genome sequences. However due to multiple internal deletions the
streptin ICE-like region present in the genome of the two serotype
M1 strains is only ,10 kb in size. The genome sequences of the
serotype M3, M5, M6, and M18 strains (all sof negative) lack an
analogous streptin ICE-like region. The G+C content of this
element in all 5 strains with the ,15 kb intact form is 31.9%,
a value considerably less that the 38.5% GAS genome average,
consistent with interspecies gene horizontal transfer.
Analysis of bacteriocin production by GAS strains of many
different serotypes has found that serotype M2, M12, and M28
strains produce a bacteriocin resulting in a P-type 777 growth
Table 1. Characteristics of Sequenced GAS Strains
..................................................................................................................................................
Strain M type MLST sof Size, bp % G+C CDS Elements
No. % Phage ICE
SF370 1 28 neg 1,852,441 38.51 1,697 83.79 4 1
MGAS5005 1 28 neg 1,838,554 38.53 1,865 86.39 3 1
MGAS10270 2 55 pos 1,928,252 38.43 1,987 87.18 5 2
MGAS315 3 15 neg 1,900,521 38.59 1,865 85.76 6 0
SSI-1 3 15 neg 1,894,275 38.55 1,861 84.61 6 0
MGAS10750 4 39 pos 1,937,111 38.31 1,979 87.16 4 2
Manfredo 5 99 neg 1,841,271 38.62 1,803 86.72 5 0
MGAS10394 6 382 neg 1,899,877 38.69 1,886 87.28 8* 0*
MGAS2096 12 36 pos{ 1,860,355 38.73 1,898 87.39 2 2
MGAS9429 12 36 pos{ 1,836,467 38.54 1,878 87.81 3 1
MGAS8232 18 42 neg 1,895,017 38.55 1,845 85.23 5 0
MGAS6180 28 52 pos 1,897,573 38.35 1,894 87.09 4 3
*Element 10394.4 is composite element that has a phage-like 59 end and an ICE-like 39end.
{Strains MGAS2096 and MGAS9429, like most serotype M12 strains, although sof positive by PCR are phenotypically Sof negative due to internal gene mutations.
doi:10.1371/journal.pone.0000800.t001
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M4, M5, M6, and M18 strains do not [65]. Thus, with the
exception of serotype M4 strains, the results parallel the
distribution of the 15-kb form of this ICE among the sequenced
GAS genomes. Serotype M4 strains have a unique bacteriocin
growth inhibition profile, P-type 655 attributed to the production
of both streptin and salivaricin A [65,66]. Consistent with this
finding, the M4 strain MGAS10750 genome has an intact ,10 kb
locus of seven genes (salR-K-Y-X-T-M-A; MGAS10750_-
Spy1722-28), encoding for production of salivaricin (for a diagram
of the sal gene locus see ref. 116). The salivaricin genes are located
39 adjacent to 10750-RD.2 (Fig. 3 site S). A homologous gene
Figure 1. Genome circular atlases. (A) MGAS10270, (B) MGAS10750, (C) MGAS2096, and (D) MGAS9429. Data from outermost to innermost circles are
in the following order. Genome size in mega base pairs (circle 1). Annotated coding sequences on the forward (circle 2) and reverse strands (circle 3)
are in dark and light blue, respectively. Reference landmarks (circle 4) illustrated are: ribosomal RNAs in green, FCT region in gold, transposons in
purple, prophages in red, ICEs in royal blue, and Mga regulon region in brown. Comparison of gene content to the 11 other sequenced GAS strains
(circle 5) is given as a gradient of nucleotide sequence similarity from low in blue to high in red. CDS percent G+C content (circle 6) with greater than
and less than average in red and blue, respectively. Net divergence of CDS dinucleotide composition (circle 7) from the average is in orange. Codon
adaptation index, that is codon use consistent with that of highly expressed genes (circle 8) with greater than and less than average in red and green,
respectively. Additionally for the two serotype M12 strains a comparison of gene content relative to each other (circle 9) is given as a gradient of
nucleotide sequence similarity from low in blue to high in red.
doi:10.1371/journal.pone.0000800.g001
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deletions in salT and/or salM that preclude SalA production [66].
Although the 30.5% G+C content of this region suggests it is not
endogenous to the GAS genome, it lacks gene content character-
istic of either phage or ICE.
The streptin element in the 5 strains in which it is intact has an
average of 1 SNP every 175 nt. This level of sequence poly-
morphism is similar to the average of 1 SNP every ,120 nt
frequency present serotype-to-serotype among the sequenced GAS
strain core chromosomes. In addition, very few SNPs present in
this element were common to strains of different M protein
serotypes. These genetic features strongly favor the likelihood that
these sof positive serotypes, each possessing the streptin gene locus,
share a common ancestor. That is, acquisition of the streptin ICE
by lateral transfer occurred before the divergence of the genomes
of distinct M protein serotypes that contain this element.
Exogenous genetic element 2096-RD.2 encoding
tetracycline resistance
Although most studies of antimicrobial agent resistance in GAS
have focused on macrolides such as erythromycin, increasing
emphasis is being placed on analysis of strains resistant to
tetracycline, either alone or in combination with macrolides
[67]. Tetracycline resistance in GAS is mediated either by tet(M) or
tet(O), genes which encode proteins that protect the ribosome [67].
The occurrence of the tet(M) gene in GAS has been known for
some time, whereas the presence of the tet(O) gene in this species
was reported relatively recently [68,69].
Our primary impetus for sequencing the genome of serotype
M12 strain MGAS2096 was its documented association with acute
poststreptococcal glomerulonephritis. We found that this genome
has a unique 63-kb ICE-like element (designated 2096-RD.2)
encoding several antibiotic resistance genes including tet(O) (Fig. 4
panel A). This ICE-like element is both the largest and has the
highest G+C content (43%) of the exogenous elements present in
the 12 sequenced GAS strains (Table 2). 2096-RD.2 is integrated
at the 39 end of a tRNA uracil methyltransferase gene (SF370:
Spy1346). 6180-RD.1 occupies the analogous site in the genome
of the sequenced serotype M28 strain, however these two ICEs
have almost no genes in common (Table 2, Fig 3). The tet(O) gene
(MGAS2096_Spy1149) encoded by 2096-RD.2 is .98% identical
to tet(O) gene found in Streptococcus mutans, Streptococcus pneumoniae,
and Campylobacter jejuni. 2096-RD.2 also has an acetyltransferase
gene (MGAS2096_Spy1118) encoding a product with 47%
identity and 66% similarity to Vat(B), a protein conferring
resistance to streptogramin A in Staphylococcus aureus [70]. In
addition, the 2096-RD.2 element has a gene (MGAS2096_-
Spy1113) that encodes a hydrophobic protein with ,65% amino
acid similarity to Na
+-driven multi-drug efflux pumps (MATE
proteins) found in Clostridium tetani, Listeria monocytogenes, and
Porphyrmonas gingivalis, and several other species of pathogenic
bacteria. Thus 2096-RD.2 has multiple genes which likely confer
resistance to antimicrobial agents.
Notably, 2096-RD.2 also has a 4,146-bp gene (MGAS2096_-
Spy1156) encoding a large predicted exported protein with an
aminoterminal secretion signal sequence and a carboxyterminal
cell-wall anchoring motif (TPKTG) (Fig. 5). This ,150 kDa acidic
protein has a pI of 4.4, and one-fourth of its 1382 amino acids
have charged side-chains. Amino acid residues 328–1330 have
similarity to Cna, a collagen-adhesion virulence factor and vaccine
candidate made by S. aureus [71]. The similarity is due mainly to
eight regions of ,75 amino acids each resembling the B domain of
Cna that form a beta sandwich extended stalk structure [72,73].
The amino-terminal end of the mature protein (residues 33–300),
although lacking significant similarity to proteins of known
function, has a 70 amino acid invasin domain as defined by the
intimin protein of enterohemorrhagic and enteropathogenic
Escherichia coli. Based on these domain similarities MGAS2096_-
Spy1156 may function as a cell surface adhesin/invasin. Inasmuch
as serotype M12 strain MGAS2096 was cultured from a patient
with APSGN, and that the 2096-RD.2 ICE is not present in the
other sequenced GAS strains including the M12 pharyngitis isolate
MGAS9429, the unique proteins encoded by this element
warrant further investigation in the context of glomerulonephritis
pathogenesis.
Genetic element 10270-RD.2 and association with
puerperal sepsis
The genome of serotype M2 strain MGAS10270 has a 35-kb ICE-
like region of difference (designated 10270-RD.2) that is virtually
identical to a recently-described exogenous genetic element (6180-
RD.2) present in the genome of all serotype M28 strains [29]. An
analogous ICE is not present in the genome of the other 10
sequenced GAS strains (Fig 3 site M). ICE 10270-RD.2 is
Figure 2. Aligned GAS genomes. Illustrated are linear diagrams of the four newly determined GAS genome sequences and regions of conserved
gene content in pair-wise comparisons. Shown for each genome diagram in green are the six rRNA operons, in red are prophages, and in blue are
ICEs. Whole-genome comparisons were made using BLASTN (www.webact.org, e=1610
24, word size=18 nt) and the graphic depictions of the
alignments were made using the Artemis Comparison Tool (www.sanger.ac.uk/Software/ACT/). Regions of conserved syntenic gene content are
indicated by blocks of salmon linking the stacked genome diagrams. Nearly all regions of discontinuity in the genome alignments are attributable to
exogenous genetic elements.
doi:10.1371/journal.pone.0000800.g002
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..................................................................................................................................................
M-type, Strain Exogenous Element Virulence Gene(s) CDS Start CDS Stop Size (kbp) Percent G+C
M1, SF370
370.1 speC-spd1 0655 0712 40.9 39.3
370.2 speH-speI 0937 1008 42.5 38.0
370-RD.1 srtA 1075 1088 12.2 33.2
370.3 spd3 1436 1488 33.5 38.0
370.4 none* 2122 2147 13.6 36.8
M1, MGAS5005
5005-RD.1 srtA 0797 0816 12.2 33.2
5005.1 speA2 0995 1052 38.1 38.0
5005.2 spd3 1168 1222 33.4 37.7
5005.3 sda 1414 1467 40.8 39.8
M2, MGAS10270
10270.1 speC-spd1 0536 0598 44.1 38.0
10270.2 spd3 0796 0853 37.9 38.2
10270-RD.1 srtA 0910 0932 17.5 31.9
10270.3 speK-sla 1297 1361 41.8 38.5
10270-RD.2 R28 1378 1411 34.7 34.5
10270.4 none 1874 1896 14.3 36.9
10270.5 none 1917 1951 11.8 36.6
M3, MGAS315
315.1 none 0681 0736 39.5 37.8
315.2 ssa 0919 0978 41.1 38.3
315.3 spd4 1094 1145 34.4 38.0
315.4 speK-sla 1203 1266 61.8 38.6
315.5 speA3 1300 1354 38.2 38.0
315.6 sdn 1408 1458 40.0 39.7
M3, SSI-1
SPsP1 sdn 0408 0456 40.0 39.7
SPsP2 speA3 0507 0561 38.2 38.1
SPsP3 speK-sla 0597 0659 41.8 38.6
SpsP4 spd4 0717 0771 34.4 38.0
SPsP5 none 0877 0937 41.0 38.2
SPsP6 ssa 1118 1172 39.9 37.7
M4, MGAS10750
10750.1 speC-spd1 0560 0622 43.8 38.0
10750.2 spd3 0831 0889 37.9 38.3
10750-RD.1 srtA 0945 0967 17.6 31.9
10750.3 ssa 1276 1328 35.6 38.0
10750-RD.2 erm(A) 1679 1719 48.9 31.2
10750.4 none 1897 1921 13.9 35.2
M5, Manfredo
man.1 spd3 0471 0535 41.4 38.6
man.2 spd4 0631 0692 36.0 37.9
man.3 speH-speI 1021 1070 39.9 38.2
man.4 speC-spd1 1263 1322 40.7 38.2
man.5 none 1764 1779 12.3 36.9
M6, MGAS10394
10394.1 sdn 0020 0068 39.9 39.7
10394.2 speA4 0733 0741 8.8 32.2
10394. 3 speK-sla 0982 1026 33.2 38.0
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PLoS ONE | www.plosone.org 6 August 2007 | Issue 8 | e800integrated into a tRNA-Thr, is ,35% G+C, is flanked by 16-bp
direct repeats, and has seven genes encoding proteins with
predicted secretion signal sequences. Included among these
proteins are cognates of Spy1325 and R28 (MGAS10270:
Spy1399 and Spy1410, respectively). Spy1325 and R28 are cell
surface anchored adhesins that are expressed during the course of
human infection, and are immunoprotective in mouse models of
infection [74,75]. Importantly 10270-RD.2 and 6180-RD.2 are
closely related to genetic elements present in strains of group B
Streptococcus, the leading cause of maternal-neonatal infections in
the United States and elsewhere. Including R28, four of the seven
inferred extracellular proteins encoded by 6180-RD.2 are made
during GAS infection [74,75]. Excluding differences in the
number of repeat domains in the gene encoding R28, 2096-
RD.2 and 6180-RD.2 differ by only 8 SNPs. This is one SNP on
average every ,4.4-kb, a frequency 38-fold lower than the core
chromosome of strains MGAS2096 and MGAS6180. The very
high level of sequence similarity between 2096-RD.2 and 6180-
RD.2 means these elements descend from a recent common
ancestor and have undergone lateral gene transfer. The occur-
rence of this ICE in the M2 and M28 clonal lineages is noteworthy
because these serotypes have been repeatedly nonrandomly
associated with GAS maternal-fetal infections [17,18,46,76]. This
epidemiological association and the similarity with sequences of
GBS, implicate the 2096-RD.2/6180-RD.2 element in contribut-
ing to maternal-fetal infections caused by serotype M2 and M28
strains.
Element 10750-RD.2 encoding erythromycin
resistance
Resistance of GAS to macrolide antibiotics has increased
dramatically in the last 10 years and is now a worldwide problem
[38]. The great majority of macrolide-resistant GAS strains have
either the mef(A) gene encoding a drug efflux pump (M resistance
phenotype) or the erm(A) gene encoding an erythromycin ribosome
dimethyltransferase (MLSB resistance phenotype) that modifies
a highly conserved adenine residue located in the target bacterial
23S rRNA [77,78]. Macrolide resistance has been reported to be
transferable by conjugal plasmids, phages, and conjugative
transposons [68,79–84]. Consistent with these observations, the
mef(A) and erm(A) genes each has been found in association with
M-type, Strain Exogenous Element Virulence Gene(s) CDS Start CDS Stop Size (kbp) Percent G+C
10394.4
{ mef(A), R6 1123 1173 58.9 38.2
10394.5 speC-spd1 1194 1242 31.9 38.4
10394.6 sda 1338 1366 24.5 40.4
10394.7 spd3 1540 1562 21.1 39.5
10394.8 none 1804 1824 13.9 36.6
M12, MGAS2096
2096.1 speC-spd1 0553 0602 41.3 39.1
2096-RD.1 srtA 0869 0890 17.5 31.9
2096-RD.2 tet(O) 1103 1159 63.0 43.1
2096.2 sda 1440 1492 40.8 39.8
M12, MGAS9429
9429.1 speC-spd1 0532 0594 41.3 38.0
9429.2 speH-speI 0795 0851 17.5 38.1
9429-RD.1 srtA 0911 0934 63.0 31.9
9429.3 sda 1415 1468 40.8 39.8
M18, MGAS8232
8232.1 speA1 0336 0394 39.0 37.7
8232.2 speC-spd1 0716 0779 41.1 38.2
8232.3 speL-speM 1238 1309 46.7 37.6
8232.4 spd3 1444 1506 38.4 37.7
8232.5 sda 1745 1808 41.8 38.5
M28, MGAS6180
6180-RD.0 srtA 0771 0793 17.5 31.9
6180.1 speC-spd1 0967 1033 46.3 37.2
6180-RD.1 none 1079 1089 11.1 30.7
6180.2 speK-sla 1220 1285 42.3 38.4
6180-RD.2 R28 1302 1337 36.3 35.0
6180.3 none 1789 1813 14.3 36.8
6180.4 none 1840 1864 11.8 36.6
*There are no known or obvious virulence genes.
{Element 10394.4 is chimeric, composed of a phage-like 59 end and an ICE-like 39end.
doi:10.1371/journal.pone.0000800.t002
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PLoS ONE | www.plosone.org 7 August 2007 | Issue 8 | e800Figure 3. GAS metagenome exogenous elements. Illustrated are loci of integration of phages and ICEs into the core chromosome. Prophages are
indicated with triangles and ICEs with squares. Stacked triangles and squares indicate a common integration site. Elements are color-coded to
indicate the source strain. Prophages and ICEs are numbered as they occur clockwise around the core chromosome for each strain. Integration loci
are lettered alphabetically as they occur clockwise around the core chromosome. The six rRNA operons are shown as green bars. Gene designations
are as follows: 1) secreted pyrogenic-toxin-superantigens: speA, speC, speH, speI, speK, speL, speM, and ssa; 2) secreted DNAses: sda, sdn, spd1, spd3,
and spd4; 3) secreted phospholipase: sla; 4) antimicrobial resistance: erm(A), mef(A), and tet(O); 5) cell surface adhesins: R6 and R28; 6) none, these
elements lack a known or obvious virulence gene.
doi:10.1371/journal.pone.0000800.g003
GAS Metagenome Diversity & ICE
PLoS ONE | www.plosone.org 8 August 2007 | Issue 8 | e800a very large number of distinct emm types [32–34,43,44,85–87]. In
addition, we recently reported that the mef(A) gene of macrolide
resistant M6 strain MGAS10394 is encoded by an unusual 58.8-kb
chimeric genetic element (Fig. 3 site J) with conjugative transposon
and prophage characteristics [26,85].
One of our motivations for sequencing the genome of erm(A)-
positive serotype M4 strain MGAS10750 was to characterize the
genetic element containing the macrolide resistance-conferring
gene in this strain. The erm(A) gene was present on a 49-kb
exogenous element designated 10750-RD.2 that is integrated into
the hsdM gene encoding host DNA restriction-modification
methyltransferase (SF370: Spy1906) (Fig. 3 site S, Fig. 4 panel
B). The gene content of this ICE is largely unique to the strain
MGAS10750 genome. The erm(A) gene in this strain is identical to
the erm(TR) sequence initially reported in GAS by Seppala et al.
[78], and its product is 81.1% identical to Erm(A) of S. aureus [88].
Just 59 of erm(A) are two adjacent CDS (SpyM4_1701 and 1702)
that encode the ATP-binding and membrane permease compo-
nents of an ABC transporter. The products of these genes have
66.7% and 44.5% similarity with TnrB2 and TnrB3 respectively,
of Streptomyces longisporoflavus a producer of tetronasin, a polyether-
ionophore antibiotic. TnrB2 and TnrB3 form an ATP-dependent
efflux system that confers resistance to tetronasin [89]. Just 39 of
erm(A) is a CDS (SpyM4_1705) predicted to encode a phospho-
transferase. The product of this gene has 25.6% identity and
39.9% similarity with the last 220 amino acids (residues 122–340)
of the spectinomycin resistance aminoglycoside phosphotransfer-
ase gene, aph,o fLegionella pneumophila [90]. This conserved region
includes the catalytically important residues defined for Aph(3) and
Aph(9) [91].
Two of the 10750-RD.2 element CDSs are predicted to encode
proteins with conventional gram-positive secretion signal se-
quences, suggesting that they are secreted extracellularly (Fig. 4
panel B). SpyM4_1694 is predicted to encode a hydrophilic
mature protein (residues 31–783) of 87.7 kDa. This protein is of
unknown function but has similarity with many proteins including
M protein due to the presence of a central (,250–525 aa) laminin-
and myosin-like coiled-coil domain (PFAM: PF00608 and
PF01576 respectively). Notably, the top 10 alignments identified
using BLASTP to compare SpyM4_1694 with the NCBI non-
Figure 4. ICEs encoding antimicrobial resistance genes. (A) 2096-RD.2 encoding Tet(O). (B) 10750-RD.2 encoding Erm(A). Illustrated are predicted
coding sequences with gene numbers and predicted functions. Gene numbers given in red denote unique gene content as determined by BLASTP
comparison to the GAS metagenome (no hit at e=1610
26). CDS are color coded to designate functionally related groups: red, antimicrobial
resistance; green, secreted and cell surface; blue, mobilization and transfer; violet, element maintenance; yellow, transcriptional regulation; grey,
hypothetical and unclassified.
doi:10.1371/journal.pone.0000800.g004
Figure 5. Domain architecture of putative cell surface acidic protein MGAS2096_Spy1156. The protein has a conventional Gram-positive secretion
signal sequence and a tripartite (TPKTG, membrane span, positively charged anchor) cell wall attachment domain. The aminoterminal portion of the
protein has an intimin/invasin-like domain (Structural Classification of Proteins superfamily: SSF49373) and shares similarity (45% from amino acid
,50-to-350) with a putative cell surface protein of unknown function (lmo1115) in the genome sequence of the intracellular pathogen Listeria
monocytogenes strain EGD-e. The carboxyterminal portion of the protein (,315-to-1350) has 8 Cna B-type domain repeats (Protein Family: PF05738)
and shares similarity with multiple proteins annotated as collagen-binding. These characteristics suggest this protein may function as an adhesin/
invasin.
doi:10.1371/journal.pone.0000800.g005
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proteins. SpyM4_1695 is predicted to encode a mature acidic
protein (residues 27–289, pI 4.2) of 29.7 kDa. The function of this
protein is unknown. SpyM4_1695 lacks significant similarity to
proteins of known function, and to known protein domains as
determined using either EMBL InterPro- or NCBI conserved
domain-searches. Inasmuch as the majority of secreted and cell
surface proteins identified in GAS have proven or putative roles in
host-pathogen interaction, these predicted extracellular proteins
are candidates for further investigation.
Fibronectin-binding collagen-binding T antigen
(FCT) gene region
The FCT gene region is an ,11–16 kb region that encodes
global-regulators and extracellular matrix-binding proteins in-
volved in cell adhesion and invasion [92–98]. Recently, Mora et
al. [99] reported that the FCT region genes encode extended
pilus-like structures composed in part of polymerized T-antigen
protein subunits. Importantly, immunization of laboratory animals
with either GAS or GBS pilin proteins has been shown to provide
protection against experimental invasive infections caused by these
pathogens [99–101]. More recently these pilus components were
shown to mediate adhesion to human pharyngeal and skin cells
and participate in biofilm formation [102,103]. We compared the
FCT gene regions in the 12 sequenced GAS strains and identified
six distinct variants, including four (I, II, III, and IV) that have
been previously described (Fig. 6). Two variants, V in serotype M4
strain MGAS10750 and VI in serotype M2 strain MGAS10270,
have not been described previously, thereby expanding our
understanding of sequence variation in this region. A portion of
the FCT region gene content in the serotype M2 strain is more
related to genomic islands present in six sequenced GBS strains
than to the other GAS variants [104,105], consistent with the idea
that horizontal gene transfer has contributed to diversification in
this chromosomal segment. Thus, the serotype M2 clonal lineage
has two gene regions (FCT and 10270-RD.2) that are closely
related to genetic elements in GBS. The similarity of these
elements between these two pathogens provides additional support
for the hypothesis that the extracellular products encoded by these
two regions contribute to the ability of M2 GAS strains to cause
puerperal sepsis infections.
DISCUSSION
The 12 GAS genomes now available represent serotypes re-
sponsible for ,70% of M protein serotypes that most commonly
cause GAS pharyngitis and invasive infections in several countries
in the western hemisphere [17,18,21,22,24,45,46,106]. Although
these 12 genome sequences provide extensive information to assist
studies of virulence, development of therapeutics and diagnostics,
and other aspects of GAS biology, a cautionary note is required.
There is considerable variation in prophage content and pro-
phage-associated virulence factor profile among strains of the same
M type [26,27,29,45,46,59,106–109]. In addition, strains of
certain M types are not necessarily clonally related [13,56,110].
This intra-M type genetic heterogeneity can mediate significant
differences in host-pathogen interactions, as documented recently
for distinct clones of serotype M1 and M3 GAS [56,107].
Similarly, many of the genomes contain large segments of
exogenous (foreign), non-prophage DNA acquired by lateral gene
transfer events. In the case of serotype M1 GAS, an apparent
episode of generalized transduction contributed to the evolution of
a new, unusually virulent clone that increased dramatically in
frequency since the mid 1980s [56]. Other foreign DNA segments
may have been acquired by conjugative transposition as
exemplified by the ICE-like elements we have described. Regard-
less of the exact gene transfer mechanism involved, the key point is
that the intraspecies gene content and allelic diversity present in
the GAS metagenome is extensive, and can impart important
Figure 6. GAS metagenome FCT region variants. (A) Architecture of the FCT region variants. CDSs are colored to designate the following groups:
black, conserved flanking genes (SF370: 59 Spy_0123 and 39 Spy_0136); yellow, transcriptional regulators; red, extracellular matrix-binding and/or
pilin-subunit proteins; tan, signal peptidases; green, sortases; purple, insertion sequences. Although there are differences both intra- and
interserotype indicative of antigenic variation, nearly all of the extracellular matrix-binding proteins and pilin-subunit proteins have predicted
secretion signal sequences and cell wall attachment domains in one or more of the genomes. Additionally illustrated is the similarity between the
serotype M2 and GBS pilus encoding region proteins in global alignments. (B) Relationships among the FCT region variants. Nucleotide sequences
bounded by the flanking conserved genes for the each of the sequenced GAS strains and the five GBS genes in panel A, were aligned with ClustalW
and a neighbor-network was generated using SplitsTree.
doi:10.1371/journal.pone.0000800.g006
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sequencing of additional GAS strains continues to reveal an
unappreciated magnitude of species-level population genomic
diversity.
Given the increasing prevalence of drug-resistant strains of
GAS, it is important to note that these genome sequences have
provided new information about the putatively-mobile genetic
elements involved. The ICEs associated with genes conferring
resistance to macrolide and tetracycline antibiotics are chimeric
structures composed of the multiple drug-resistance genes, genetic
machinery to mediate lateral transfer, and genes encoding putative
or proven novel extracellular proteins [26,83,85]. In the case of the
mef(A) element in serotype M6 strain MGAS10394 and other
strains, it is known from serologic studies that the extracellular
protein designated R6 is expressed during human infections
[26,85]. The putative extracellular proteins encoded by the erm(A)
and tet(O) encoding elements, 10750-RD.2 and 2096-RD.2
respectively, have not yet been analyzed in detail. However, since
they contain conventional gram-positive secretion sequences and
some have carboxyterminal cell wall attachment motifs, we
speculate that these proteins are either displayed on the GAS cell
surface and function to mediate adherence to host molecules, or
are secreted free into the extracellular environment and interact
with host molecules. Given that the drug-resistance genes are
widespread in Gram negative and positive respiratory tract
organisms, and dispersed among many distinct GAS M protein
types, we think it likely that further study will identify additional
genetic elements associated with drug resistance [33–
37,40,41,43,44,51,68,69,80,85–87,111–117]. Consistent with this
hypothesis, an element containing both mef(A) and tet(O) genes was
described recently [86]. We note that the various genetic elements
associated with tet(O), mef(A), erm(A) likely helps to explain some of
the confusing data in the literature regarding the nature and mode
of spread of drug-resistant markers in GAS [68,80–82,84].
One feature of the horizontally transferred regions encoding
antibiotic resistance determinants in the GAS metagenome that is
of concern is the high level of homology between the genes
putatively involved in mobilization and transfer of these elements
and genes found in other genera and species of human pathogens
such as staphylococci, enterococci, clostridia, and streptococci (S.
pneumoniae and S. agalactiae, for example). Additionally the finding
that the ICEs present in the GAS genome (more so than the
prophages) differ significantly in nucleotide composition from the
core chromosome argues that they originate from organisms not
closely related to the streptococci. This underscores the potential
extensiveness of accessible virulence genes, and the relative lack of
barriers to horizontal gene transfer among pathogenic bacteria.
The horizontally acquired chimeric elements can provide an
immediate selective advantage to recipient bacteria, for example
by conferring antibiotic resistance. In addition, the conserved
regions of these mobile elements enhance the potential for further
future recombination/integration events with horizontally trans-
ferred DNA. Thus, these foreign elements likely increase the
frequency with which regions of horizontally transferred DNA are
retained in the chromosome of recipient bacteria.
The addition of these four complete genome sequences to the
eight previously determined makes the GAS metagenome one of
the better characterized among important human pathogens. The
new gene content found in the ICE-like elements and the FCT
regions described in these four genomes encodes proteins
providing antimicrobial resistance and proven and putative
extracellular adhesin/invasin proteins. Thus the sequencing of
these four additional genomes has provided much-needed in-
formation about the genetic diversity present in GAS and has
revealed factors likely affecting the virulence of these strains.
Although medical intervention limits human morbidity and
mortality due to GAS in the western countries, globally it has
a tremendous toll on human health. This is especially the case in
countries with less developed medical systems for which there is
relatively little information available about the circulating strains.
One future challenge will be to determine to what extent the
metagenome of GAS as defined by the twelve currently sequenced
strains originating in the western hemisphere is representative of
disease causing strains circulating in other areas of the world.
Given the considerable role played by mobile exogenous elements
in GAS genetic diversity and pathogenesis, this information is
crucial to understanding the array of molecular mechanisms used
by GAS to cause human disease, and is of paramount importance
to vaccine and therapeutics research.
MATERIALS AND METHODS
Bacterial strains
The four GAS strains sequenced, serotype M2 Strain
MGAS10270, M4 strain MGAS10750, and M12 strains
MGAS2096 and MGAS9429 were each isolated from human
infections of defined disease type. These four strains have been
deposited in the American Type Culture Collection under the
following accession numbers: MGAS10270 (BAA-1063),
MGAS10750 (BAA-1066), MGAS2096 (BAA-1065), and
MGAS9429 (BAA-1315).
Genome sequencing
Standard methods were used to determine the complete genome
sequence of the M2, M4, and two M12 strains as previously
described [26,29]. Briefly, short sequencing templates were
generated from sheared chromosomal DNA fragments cloned
into a plasmid vector and sequenced from each end. The resulting
random sequence reads were assembled in silico into larger
contiguous segments, and contigs were ordered using the GAS
metagenome as a scaffold. Sequence gaps were closed by directed
sequencing of gap-spanning templates obtained by PCR amplifi-
cation. Additional directed sequencing was performed as necessary
to improve sequence quality genome-wide to a minimum base call
error rate of 1 in 10,000 (i.e. Q40). Each genome was tiled by PCR
after closure to validate the in silico assembly. Coding sequences
were identified with proprietary software (Integrated Genomics,
Chicago, IL), annotated, and analyzed with the ERGO bioinfor-
matics suite [118]. The genome sequences have been deposited in
the National Center for Biotechnology Information microbial
genome database under the following accession numbers:
MGAS10270 (CP000260), MGAS10750 (CP000262),
MGAS2096 (CP000261), and MGAS9429 (CP000259). An
analysis of polymorphisms present in the core chromosomes of
these strains and their relationship with the other 8 sequenced
GAS genomes has recently been published [119].
Identification of endogenous and exogenous
sequences
Sequence common to the GAS genomes constituting the
endogenous metagenome core, were identified by a combination
of genomic alignment and gene content comparisons. Exogenous
putatively-mobile elements such as prophages and integrating
conjugative elements (ICEs) were identified by a combination of
genomic alignment, gene content, nucleotide composition, and
codon usage comparisons. First, by comparative genome sequence
alignments (such as MUMmer plots) these regions differ in gene
GAS Metagenome Diversity & ICE
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genomes. That is, they are an insertion or deletion. Second, they
contain modules of genes with similarity to genes previously
identified in and considered to be characteristic of mobile genetic
elements. For example, prophages have genes encoding coat and
tail proteins, and ICEs have genes encoding recombinases,
relaxases and excisionases. In addition, prophages and ICEs were
differentiated in part by the gene content they lacked, consistent
with their known modes of lateral transfer. For example, unlike
prophages, ICEs lack genes encoding holins and peptidoglycan
lytic enzymes. Third, many ICEs and prophages are flanked by
directly repeated attachment sequences, attP-L and attP-R, that
are generated as a consequence of the homologous-recombination
event mediated by the related prophage and ICE site-specific
integrases. Fourth, these elements often contain genes that are
most similar in sequence to genes of other bacterial species that
sometimes differ from GAS in preferred codon usage, % G+C
content, and multimer nucleotide (di-, tri-, tetra-) composition,
consistent with intraspecies lateral transfer. Importantly, there is
no single distinct gene complement that differentiates among
various types of bacterial mobile genetic elements (phage,
conjugative plasmids and transposons, insertion sequences, etc.).
Thus, ICEs and prophages were identified on the basis of
a preponderance of genetic characteristics identified during
annotation, rather than use of a single genetic characteristic. For
simplicity, integrated foreign elements that have many but not all
of the features described above (that is, ICE-like or prophage-like
traits) will be referred to in this report as ICEs and prophages.
Together, these elements are referred to as exogenous genetic
elements.
Sequence alignments and comparisons
Genome alignments and identification of SNPs were performed
using MUMmer [120]. Genomic gene content and NCBI non-
redundant sequence database comparisons were performed using
BLAST [121]. Pair-wise global and local gene and protein
alignments were performed using the ‘‘needle’’ (Needleman-
Wunsch) and ‘‘water’’ (Smith-Waterman) applications respectively
of EMBOSS [122]. Multiple sequence alignments were performed
using ClustalW or Muscle [123,124]. Reconstruction of genetic
relationships were performed using SplitsTree [125]. Protein motif
searches were performed using the EMBL InterPro scan and
NCBI conserved domain servers [126,127]. Codon usage and
nucleotide composition analyses were performed using CodonW
(bioweb.pasteur.fr). Various other analyses (M.W., pI, hydrophi-
licity, etc.) were performed using MacVector [128]. Circular
genome atlases were generated using GenomeViz [129]. Sche-
matics of the aligned genomes were generated using the Artemis
Comparison Tool [130].
SUPPORTING INFORMATION
Table S1 New GAS Metagenome Genes
Found at: doi:10.1371/journal.pone.0000800.s001 (0.37 MB
DOC)
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